JOURNAL OF BUON, cilt.17, sa.4, ss.669-676, 2012 (SCI İndekslerine Giren Dergi)
Purpose: To determine the clinical features of bevacizumab-associated toxicities in metastatic colorectal cancer (MCRC) patients.